MetaCap

Akebia Therapeutics Statistics

NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.3855-0.0368 (-8.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Akebia Therapeutics by the numbers

Akebia Therapeutics has a market capitalization of $107.0 million based on 277.66M shares outstanding. With trailing EPS of $-0.17, Akebia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 46.1% below its 50-day average and 64.3% below its 200-day average.

Average daily trading volume is 8.05M shares, or about $3.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AKBA valuation vs. peer median

AKBA compared with the median of 8 peer companies
MetricAKBAPeer medianDifference
Market cap$107.04M$108.89M-2%
Avg. volume8.05M334.55K+2307%

Peer median across 8 companies: BGM, SPRB, MENS, GNLX, FHTX, IMUX, OKUR, ORGO.

Valuation

Market cap
$107.04M
Price / sales (latest FY)
0.45
EPS (TTM)
$-0.17

Price and trading

Previous close
0.4223
Open
0.41
Day range
0.3849 – 0.4331
52-week range
0.361 – 1.73
52-week change
-75.13%
Beta
—
Volume
4.57M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
107.04M
Forward Pe
-0.84
Eps
-0.17
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.73
Week52 Low
0.36
Avg Volume
8.05M
Shares Outstanding
277.66M
Ma50
0.72
Ma200
1.08
Earnings Date
Nov 5, 2026
Pct From52w High
-77.72%
Pct From52w Low
6.79%

Related